Skip to main content
. 2019 Dec 28;8(1):56. doi: 10.3390/microorganisms8010056

Table 1.

Characteristics of all pregnant women.

Characteristics Patient #1 Patient #2 Patient #3 Patient #4 Patient #5
days after symptoms onset 5 16 31 59 74 165 198 107 154 34 95 11 56 60 3 months post-partum
ZIKV RNA in blood Pos Pos Pos Pos Pos Pos Neg Pos Pos Pos Pos Neg
ZIKV RNA in urine Pos Pos Neg Pos Neg Neg Pos Neg
ZIKV RNA in saliva Pos Neg Neg Neg Pos Neg Neg
ZIKV RNA in AF Neg Neg Pos
ZIKV IgM EIA Neg Neg Neg Neg Neg Neg Pos Neg Neg
ZIKV IgG EIA Pos Pos Pos Pos Pos Pos Neg Pos Pos
ZIKV NT Abs 1:640 1:1280 1:2560 1:160 1:160 1:2560 1:2560
DENV IgM EIA Neg Neg Neg Neg Neg Neg Neg
DENV IgG EIA Pos Pos Pos Pos Pos Pos Pos
DENV NT Abs
DENV1 1:2560 1:40,000 1:640,000 1:5000 1:320 <5 <5
DENV2 1:160,000 1:640,000 1:640,000 1:320 1:320 <5 <5
DENV 3 1:640,000 1:640,000 1:640,000 1:640 1:320 <5 <5
DENV 4 1:640 1:2560 1:640,000 1:80 1:80 <5 <5
BOB assay * 0.179 0.197 0.156 0.151 0.165
ZIKV ELISPOT ** 61 81
DENV ELISPOT **
DENV1 153 5 3
DENV2 163 5 28
DENV 3 198 3 0
DENV 4 118 10 30
outcome no transmission no transmission no transmission transmission transmission

* Blockade-of-binding (BOB) assay: cut off 0.36 (confirmed Zika virus (ZIKV) Ab < 0.36), all results are expressed in ratio; ** responses are given as net spots/million PBMC, cut-off of response 30 net spots/million PBMC; EIA: enzyme immunoassay; AF: amniotic fluid; NT Abs: neutralizing antibodies; results of NT Abs < 5 are considered negative. DENV, Dengue virus.